Clinical Trial Update: Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a single intravitreal injection of 4D-150 for neovascular age-related macular degeneration is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• 4D-150

Snippet

Sponsor: 4D Molecular Therapeutics | Conditions: Neovascular Age-Related Macular Degeneration (nAMD) | Phase 3 | Status: RECRUITING